Kobayashi Pharmaceutical Co. Ltd Financials

Market Capitalization ¥443.21 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	43.67
Forward PE	25.25
Price to Sales TTM	¥2.63
Price to Book MRQ	¥2.17
Enterprise to Revenue	2.33
Enterprise to EBITDA	13.18

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	6.03%
Operating Margin	18.03%
Return on Assets TTM	5.56%
Return on Equity TTM	4.86%

Income Statement

Revenue TTM	¥168,798,994,432
Revenue per Share TTM	¥2265.30
Quarterly Revenue Growth	-9.20%
Gross Profit TTM	¥96,375,000,000
EBITDA	¥24,604,000,000
Net Income to Common TTM	¥10,183,999,488
Diluted EPS TTM	¥136.53
Quarterly Earnings Growth YoY	-48.80%

Balance Sheet

Total Cash MRQ	¥51,666,001,920
Total Cash per Share MRQ	¥694.99
Total Debt MRQ	¥
Total Debt to Equity MRQ	0.47
Current Ratio MRQ	3.20
Book Value per Share MRQ	¥2753.43

Cash Flow

Operating Cash Flow TTM	¥19,885,000,000
Levered Free Cash Flow TTM	¥20,338,000,000

4967 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	74,338,896
Float Shares	39,408,758
Avg 10 Volume	280,280
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	34.67%
% Held by Institutions	20.43%

Stock Price Summary

Beta	0.25
Fifty Two Week Low	¥4700.00
Fifty Two Week High	¥6866.00
Fifty Two Week Change	-16.30%
Day 50 MA	¥5737.94
Day 200 MA	¥5619.13

Dividends and Splits

Forward Annual Dividend Rate	¥86.00
Forward Annual Dividend Yield	1.49%
Trailing Annual Dividend Rate	¥101.00
Trailing Annual Dividend Yield	1.75%
Payout Ratio	74.04%
Dividend Date
Ex Dividend Date	2024-12-27
Last Split Factor
Last Split Date	2016-06-28